Today: 21 May 2026
Robinhood’s Earnings Week Now Has a Prediction-Market Problem
26 April 2026
2 mins read

Robinhood’s Earnings Week Now Has a Prediction-Market Problem

New York, April 26, 2026, 16:02 EDT

Robinhood Markets Inc. is staring down a new lawsuit from Wisconsin, just as it prepares to release first-quarter earnings. The state has targeted Robinhood and a group of rivals over contracts tied to sports events—a type of contract that allows traders to bet on real-world outcomes. The legal action drops a cloud of regulatory uncertainty over Robinhood right before its results hit.

Timing is key here. Robinhood will release results after Tuesday’s bell, with CEO Vlad Tenev and CFO Shiv Verma taking questions at 5 p.m. EDT. Shareholders have until Monday evening to send in their questions. The stock closed at $84.71 on Friday—a slide from Monday’s $91.28 finish, LSEG figures on the company show.

Investors want clarity on whether Robinhood’s push into event contracts, crypto, retirement products, margin lending, and private-market access will actually move the needle beyond its core business in stocks and options. In February, the company’s fourth-quarter revenue fell short of Wall Street’s targets, dragged down by softer-than-expected crypto trading revenue—even as revenue from equities and options ticked higher.

Wisconsin is suing Kalshi, Robinhood, Coinbase, Polymarket and Crypto.com, accusing them of running illegal sports betting via prediction markets. Robinhood pushed back, telling Wisconsin Public Radio its event contracts fall under CFTC oversight and that it will fight the case.

Wisconsin isn’t the only battleground. On Friday, the U.S. Commodity Futures Trading Commission filed suit against New York, arguing the state encroached on federal jurisdiction in prediction markets by targeting Coinbase and Gemini for related offerings. New York regulators counter that gambling laws come into play when platforms sell event contracts—like those pegged to sports results and similar wagers.

Opinions are divided across Wall Street about Robinhood’s recent growth. Benzinga data shows JPMorgan kept a Neutral call on the shares as of April 23, trimming its price target down to $92 from $113. Taking the most recent notes from JPMorgan, KeyBanc and Cantor Fitzgerald together, the average price target now lands at $104.

Tailwinds are showing up, too. Earlier this month, the SEC gave the green light to a FINRA plan scrapping the pattern day-trader rule — that old cap held accounts under $25,000 to just three day trades every five business days. Shares of Robinhood and Webull climbed on the news. Northland’s Mike Grondahl called it a “direct benefit” for revenue: more day trading simply means more orders, more often, per user. Reuters

Robinhood took another step overseas last week, winning in-principle approval from the Monetary Authority of Singapore to roll out brokerage services. Patrick Chan, who heads up Robinhood’s Asia operations, described Singapore as an “ideal hub.” The company noted the approval might extend to securities trading, exchange-traded derivatives, custody, product financing and funds, but stressed this approval does not yet amount to a licence. Robinhood

Robinhood took another swing at private markets. Its Ventures Fund I disclosed a roughly $75 million purchase of OpenAI common shares on April 17, offering retail clients a rare backdoor into an AI company still off public exchanges. “OpenAI was one of RVI’s largest investments to date,” said fund president Sarah Pinto. Robinhood

Robinhood shares jumped on the heels of the OpenAI news, Reuters said, but the RVI fund saw even steeper gains. Piper Sandler analysts, in a note this month, argued retail trading could hold up better than investors expect in 2026—regardless of whether rate cuts or a broad risk rally materialize.

The risks are obvious. Should state challenges bog down event contracts, or if Singapore’s full licence is delayed after the initial approval, or retail traders pull back again, Robinhood’s latest product updates might fall short of shoring up the shares.

Tuesday’s call? It comes down to numbers: funded customers, net deposits, margin balances, options activity, crypto trading, plus whatever management says about event contracts. Everything else is narrative. The market’s after evidence.

Stock Market Today

  • CyberTech Systems Earnings Raise Cash Flow Concerns Amid Market Stability
    May 20, 2026, 8:56 PM EDT. CyberTech Systems and Software Limited (NSE:CYBERTECH) posted earnings that met market expectations but revealed an accrual ratio of 0.53, indicating weaker free cash flow relative to profit. This financial metric, which measures non-cash earnings, signals potential challenges for upcoming profits as free cash flow of ₹76 million lagged behind reported profit of ₹304.3 million for the year ending March 2026. Despite a 28% annual growth in earnings per share (EPS) over three years, the decline in cash conversion may raise investor caution. The company's accrual ratio improved last year, suggesting the current shortfall could be temporary, but shareholders are advised to monitor cash flow trends closely against profitability for a clearer outlook.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
SoFi Technologies Stock Faces a Big Q1 Earnings Test as Loan Growth Comes Into Focus
Previous Story

SoFi Technologies Stock Faces a Big Q1 Earnings Test as Loan Growth Comes Into Focus

Australia Stock Market Today: ASX 200 Falls For Fifth Day As Oil Shock Hits Banks, Origin
Next Story

Australia Stock Market Today: ASX 200 Falls For Fifth Day As Oil Shock Hits Banks, Origin

Go toTop